Stonegate Capital Partners has updated its coverage on Burcon Nutrascience Corporation (TSX: BU), highlighting the company's transition from commissioning to early utilization. With commercial production now underway for Peazazz pea protein, Puratein C canola protein, and FavaPro fava protein in FY26, Burcon is positioned to benefit from growing customer volume and better fixed-cost absorption at its Galesburg facility.
In the fourth quarter of fiscal 2026, Burcon reported revenue of $0.83 million, up from $0.74 million in the third quarter. Management indicated that based on April and May activity, current-quarter sales are tracking toward approximately 50% sequential growth. The company also set a new production record, with daily output roughly 60% above levels seen from January through March. As volume builds, the margin opportunity is expected to come from better utilization, a steadier production cadence, and the removal of start-up costs from the run-rate cost structure, rather than from pricing alone.
Customer traction is broadening, with over 30 purchasing customers and more than 200 active projects across pea, canola, and fava applications. This diversification supports Burcon's ramp-up strategy. The company has secured funding to support the Galesburg scale-up, having completed $6.9 million in financing, with an additional $3.0 million undrawn. Management is targeting $10 million in sales for calendar year 2026.
Burcon's progress marks a significant milestone as it moves from development to commercial revenue generation. The increasing customer base and production efficiencies could position the company for sustained growth in the plant protein market. Investors and stakeholders can view the full announcement, including downloadable images and bios, here.
Stonegate Capital Partners is a capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets (member FINRA), offers investment banking services for public and private companies.
